Effect of Hemodialysis on the Red Blood Cell Life Span in Patients with End‐Stage Kidney Disease

The aim of this study was to use a CO breath test to investigate hemodialysis effects on red blood cell lifespan in patients with chronic kidney disease. A cohort of 17 non‐smoking men with end‐stage kidney disease undergoing hemodialysis via a polysulfone dialysis membrane (as opposed to a traditional cellulose acetate membrane) were subjected to a repeated Levitt's CO breath test to compare red blood cell lifespan before vs. after dialysis. None of the patients showed significant fluctuations in endogenous CO concentration during the dialysis procedure. The mean red blood cell lifespan was 66.0 ± 31.0 days before dialysis and 72.0 ± 26.0 days after dialysis, with no significant difference between the assessment time points (P > 0.05). In conclusion, dialysis using a polysulfone membrane did not appear to disrupt red blood cells or reduce their lifespan in patients with end‐stage kidney disease.

[1]  D. Chlubek,et al.  The impact of hemodialysis on erythrocyte membrane cytoskeleton proteins. , 2015, Postepy higieny i medycyny doswiadczalnej.

[2]  J. Minakuchi,et al.  Shortened Red Blood Cell Lifespan Is Related to the Dose of Erythropoiesis‐Stimulating Agents Requirement in Patients on Hemodialysis , 2012, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[3]  R. Walker,et al.  Red blood cell survival in long-term dialysis patients. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  G. Tsagalis Renal anemia: a nephrologist's view. , 2011, Hippokratia.

[5]  P. Dutka Guarding against hidden hemolysis during dialysis: an overview. , 2008, Nephrology nursing journal : journal of the American Nephrology Nurses' Association.

[6]  J. Vienken Biocompatibility of dialysis membranes , 2006 .

[7]  Harold I Feldman,et al.  Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. , 2005, Kidney international.

[8]  A. Yılmaz,et al.  The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. , 2004, Mediators of inflammation.

[9]  R. Vanholder,et al.  Which dialyser membrane to choose? , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  S. Ho,et al.  Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. , 2003, The Journal of laboratory and clinical medicine.

[11]  A. Pascalis,et al.  Intra- and post-dialytic platelet activation and PDGF-AB release: cellulose diacetate vs polysulfone membranes. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  C. Wanner,et al.  Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? , 2001, Kidney international. Supplement.

[13]  F. Ursini,et al.  Oxidant stress in hemodialysis: prevention and treatment strategies. , 2000, Kidney international. Supplement.

[14]  E W Young,et al.  Dialysis dose, membrane type, and anemia control. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  L. Spry,et al.  Multistate outbreak of hemolysis in hemodialysis patients--Nebraska and Maryland, 1998. , 1998, MMWR. Morbidity and mortality weekly report.

[16]  C. Ronco,et al.  Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. , 1996, Kidney international.

[17]  M. Levitt,et al.  Use of alveolar carbon monoxide measurements to assess red blood cell survival in hemodialysis patients , 1994, American journal of hematology.

[18]  R. Engel,et al.  A simple carbon monoxide breath test to estimate erythrocyte turnover. , 1992, The Journal of laboratory and clinical medicine.